TCBIO Texas Capital Bancshares Inc

Gamco Investors INC. ET AL has acquired a new stake in Texas Capital Bancshares (NASDAQ:TCBI), purchasing 31,078 shares valued at approximately $2.47 million. This investment follows a strong quarter for Texas Capital Bancshares, which reported EPS of $2.18 and revenue of $340.35 million, significantly beating analyst estimates. Despite mixed Wall Street sentiment with an average "Hold" rating, several other hedge funds have also adjusted their holdings in the bank.

Arrowstreet Capital Limited Partnership significantly increased its holdings in Texas Capital Bancshares, Inc. (NASDAQ:TCBI) by 69.8% in Q2, acquiring an additional 96,525 shares. Other institutional investors like Norges Bank also established new positions, bringing total institutional ownership to 96.88%. The company recently beat earnings estimates, reporting $2.18 EPS against an expected $1.77, and analysts currently have a consensus "Hold" rating with a target price of $88.10.

Texas Capital Bancshares (TCBI) faces potential margin pressures in 2026 due to anticipated interest rate cuts, despite exceeding its Return on Average Assets target in Q3 2025. The bank's strong capital position and share repurchase program offer opportunities for shareholder value, but analysts remain cautious about the sustainability of profitability and fee income growth. An upcoming weaker Q4 2025 performance could further complicated its long-term profitability targets.

Texas Capital Bancshares (TCBI) recently reported strong quarterly results with increased net interest income, better-than-expected profitability, and stable asset quality, attracting investor attention. Despite a 9.1% year-to-date share price increase, its one-year total shareholder return is slightly negative, while a five-year return shows 47% growth. The company is considered undervalued, with a narrative-based fair value of $92 and a discounted cash flow model suggesting it could be worth 35.8% more than its current price.

DA Davidson has reiterated a Neutral recommendation for Texas Capital Bancshares, Inc. - Preferred Stock (TCBIO). Analyst price forecasts suggest a 13.64% upside, with an average one-year price target of $23.47/share. Institutional ownership shows a decrease in the number of funds holding TCBIO and a reduction in total shares owned.

Texas Capital Bancshares, Inc. reported record-level net income and significant growth in key financial metrics for the third quarter of 2025, reflecting a successful strategic transformation. The company achieved net income of $105.2 million and diluted EPS of $2.18, alongside record book value and tangible book value per share. Management expressed optimism about future performance and continued commitment to clients, aiming to drive long-term value for stakeholders.